SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-018809
Filing Date
2024-02-22
Accepted
2024-02-22 16:26:07
Documents
121
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rgen-20231231.htm   iXBRL 10-K 4043511
2 EX-10.5 rgen-ex10_5.htm EX-10.5 48877
3 EX-19.1 rgen-ex19_1.htm EX-19.1 131744
4 EX-21.1 rgen-ex21_1.htm EX-21.1 21484
5 EX-23.1 rgen-ex23_1.htm EX-23.1 6072
6 EX-31.1 rgen-ex31_1.htm EX-31.1 12240
7 EX-31.2 rgen-ex31_2.htm EX-31.2 12246
8 EX-32.1 rgen-ex32_1.htm EX-32.1 14448
9 EX-97.1 rgen-ex97_1.htm EX-97.1 42965
10 GRAPHIC img33618189_0.jpg GRAPHIC 47767
  Complete submission text file 0000950170-24-018809.txt   19756031

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rgen-20231231.xsd EX-101.SCH 2747367
123 EXTRACTED XBRL INSTANCE DOCUMENT rgen-20231231_htm.xml XML 4200428
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-14656 | Film No.: 24665243
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)